FI101296B1 - Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi - Google Patents

Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi

Info

Publication number
FI101296B1
FI101296B1 FI915825A FI915825A FI101296B1 FI 101296 B1 FI101296 B1 FI 101296B1 FI 915825 A FI915825 A FI 915825A FI 915825 A FI915825 A FI 915825A FI 101296 B1 FI101296 B1 FI 101296B1
Authority
FI
Finland
Prior art keywords
cyclopentyloxycarbonyl
methylbenzenesulfonamide
methoxybenzoyl
indol
ylmethyl
Prior art date
Application number
FI915825A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI101296B (fi
FI915825L (fi
FI915825A0 (fi
Inventor
Martin Paul Edwards
John David Sherwood
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of FI915825A0 publication Critical patent/FI915825A0/fi
Publication of FI915825L publication Critical patent/FI915825L/fi
Application granted granted Critical
Publication of FI101296B publication Critical patent/FI101296B/fi
Publication of FI101296B1 publication Critical patent/FI101296B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI915825A 1990-12-12 1991-12-11 Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi FI101296B1 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB909027018A GB9027018D0 (en) 1990-12-12 1990-12-12 Heterocyclic compounds
GB9027018 1990-12-12

Publications (4)

Publication Number Publication Date
FI915825A0 FI915825A0 (fi) 1991-12-11
FI915825L FI915825L (fi) 1992-06-13
FI101296B FI101296B (fi) 1998-05-29
FI101296B1 true FI101296B1 (fi) 1998-05-29

Family

ID=10686919

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915825A FI101296B1 (fi) 1990-12-12 1991-12-11 Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi

Country Status (28)

Country Link
US (1) US5294636A (esLanguage)
EP (1) EP0490649B1 (esLanguage)
JP (1) JP2650807B2 (esLanguage)
KR (1) KR100194479B1 (esLanguage)
CN (2) CN1032469C (esLanguage)
AP (1) AP286A (esLanguage)
AT (1) ATE145199T1 (esLanguage)
AU (1) AU656344B2 (esLanguage)
CA (1) CA2056067C (esLanguage)
CZ (1) CZ288151B6 (esLanguage)
DE (1) DE69123123T2 (esLanguage)
DK (1) DK0490649T3 (esLanguage)
ES (1) ES2094797T3 (esLanguage)
FI (1) FI101296B1 (esLanguage)
GB (2) GB9027018D0 (esLanguage)
GR (1) GR3021605T3 (esLanguage)
HK (1) HK81497A (esLanguage)
HU (2) HU213109B (esLanguage)
IE (1) IE914316A1 (esLanguage)
IL (1) IL100090A (esLanguage)
MX (1) MX9102475A (esLanguage)
MY (1) MY108629A (esLanguage)
NZ (1) NZ240940A (esLanguage)
PH (1) PH30041A (esLanguage)
RU (1) RU2107682C1 (esLanguage)
SK (1) SK279018B6 (esLanguage)
TW (1) TW222264B (esLanguage)
ZA (1) ZA919772B (esLanguage)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2063479T3 (es) * 1990-05-04 1995-01-01 Ciba Geigy Ag Indoles substituidos.
IL100091A (en) * 1990-12-12 1998-08-16 Zeneca Ltd Pharmaceutical compositions containing a physical form of n-[4-[5-(cyclopentyloxycarbonyl)amino-1-methyl indol-3-yl-methyl]-2-methylbenzenesulpho-namide and process for their preparation
GB9119001D0 (en) * 1991-09-05 1991-10-23 Ici Plc Pharmaceutical agents
GR1001368B (el) * 1992-10-08 1993-10-29 Ici Plc Φαρμακευτικοί φορείς.
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
CN1110300C (zh) * 1993-10-01 2003-06-04 阿斯特拉公司 工艺技术ⅰ
IS1736B (is) 1993-10-01 1999-12-30 Astra Ab Aðferð og tæki sem stuðla að aukinni samloðun agna
GB9723985D0 (en) * 1997-11-14 1998-01-14 Zeneca Ltd Pharmaceutical compositions
GB9726735D0 (en) * 1997-12-18 1998-02-18 Zeneca Ltd Pharmaceutical compositions
GB9900339D0 (en) * 1999-01-09 1999-02-24 Zeneca Ltd Chemical compounds
GB0003305D0 (en) * 2000-02-15 2000-04-05 Zeneca Ltd Pyrimidine derivatives
IL139243A0 (en) * 2000-10-24 2001-11-25 Internat Specialty Products Is Ethanolate of zafirlukast, process for manufacture and pharmaceutical compositions thereof
TWI353979B (en) * 2002-04-10 2011-12-11 Nippon Zoki Pharmaceutical Co Novel crystal form of 5-hydroxy-1-methylhydantoin
US20090317476A1 (en) * 2003-07-31 2009-12-24 Robinson Cynthia B Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050026882A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
US20050113410A1 (en) * 2003-11-03 2005-05-26 Mark Tawa Pharmaceutical salts of zafirlukast
US20080254114A1 (en) * 2005-03-03 2008-10-16 Elan Corporation Plc Controlled Release Compositions Comprising Heterocyclic Amide Derivative Nanoparticles
US20070197467A1 (en) * 2006-02-06 2007-08-23 Srinivasulu Rangineni Zafirlukast compositions
US20090012146A1 (en) * 2007-07-02 2009-01-08 Giridhar Reddy Buggana Solubility-enhanced pharmaceutical compositions comprising zafirlukast
US20090191183A1 (en) * 2007-07-30 2009-07-30 Auspex Pharmaceuticals, Inc. Substituted indoles
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
WO2014012954A1 (en) 2012-07-18 2014-01-23 Takeda Gmbh Treatment of partly controlled or uncontrolled severe asthma
CN103396353B (zh) * 2013-08-23 2015-05-20 海南通用三洋药业有限公司 一种扎鲁司特无定型态及其制备方法
EP3096760A1 (en) 2014-01-22 2016-11-30 Takeda GmbH Treatment of partly controlled or uncontrolled severe asthma with a pde4 inhibitor (and in combination with a leukotriene modifier)
PT109030B (pt) * 2015-12-15 2019-09-25 Hovione Farmaciência, S.A. Preparação de partículas inaláveis de zafirlucaste
JP7272655B2 (ja) 2017-01-30 2023-05-12 ウェスタン ニュー イングランド ユニバーシティ チオールイソメラーゼ阻害剤およびその使用
WO2022243942A1 (en) 2021-05-19 2022-11-24 Quercis Pharma AG Quercetin-containing compositions for use in treating amyotrophic lateral sclerosis
WO2023214391A1 (en) 2022-05-06 2023-11-09 Quercis Pharma AG Method for treating cancers and neurological diseases using quercetin-containing compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4161516A (en) * 1975-07-25 1979-07-17 Fisons Limited Composition for treating airway disease
GB8607294D0 (en) * 1985-04-17 1986-04-30 Ici America Inc Heterocyclic amide derivatives

Also Published As

Publication number Publication date
EP0490649B1 (en) 1996-11-13
HU913863D0 (en) 1992-02-28
AU656344B2 (en) 1995-02-02
DE69123123T2 (de) 1997-03-06
KR100194479B1 (ko) 1999-06-15
CA2056067C (en) 2001-09-04
JPH04266872A (ja) 1992-09-22
TW222264B (esLanguage) 1994-04-11
MY108629A (en) 1996-10-31
KR920012031A (ko) 1992-07-25
GB2250743A (en) 1992-06-17
HU213109B (en) 1997-02-28
AP9100341A0 (en) 1992-01-31
AU8899591A (en) 1992-06-18
US5294636A (en) 1994-03-15
FI101296B (fi) 1998-05-29
MX9102475A (es) 1992-06-01
AP286A (en) 1993-09-26
ZA919772B (en) 1992-09-30
JP2650807B2 (ja) 1997-09-10
CA2056067A1 (en) 1992-06-13
GR3021605T3 (en) 1997-02-28
SK279018B6 (sk) 1998-05-06
IL100090A (en) 1996-09-12
HUT60717A (en) 1992-10-28
GB9027018D0 (en) 1991-01-30
FI915825L (fi) 1992-06-13
HK81497A (en) 1997-06-27
GB2250743B (en) 1995-02-15
ATE145199T1 (de) 1996-11-15
FI915825A0 (fi) 1991-12-11
DE69123123D1 (de) 1996-12-19
IE914316A1 (en) 1992-06-17
EP0490649A1 (en) 1992-06-17
HU211125A9 (en) 1995-10-30
CZ288151B6 (en) 2001-05-16
GB9126353D0 (en) 1992-02-12
PH30041A (en) 1996-11-08
CN1063100A (zh) 1992-07-29
ES2094797T3 (es) 1997-02-01
DK0490649T3 (da) 1997-04-21
NZ240940A (en) 1994-05-26
CN1032469C (zh) 1996-08-07
CN1074411C (zh) 2001-11-07
IL100090A0 (en) 1992-08-18
CS375891A3 (en) 1992-06-17
CN1148491A (zh) 1997-04-30
RU2107682C1 (ru) 1998-03-27

Similar Documents

Publication Publication Date Title
FI101296B1 (fi) Menetelmä yhdisteen N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yylimetyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidi kiteisen muodon ja sitä sisältävien pellettien valmistamiseksi
FI101193B1 (fi) Menetelmä N-[4-[5-(syklopentyylioksikarbonyyli)amino-1-metyyli-indol-3-yyli-metyyli]-3-metoksibentsoyyli]-2-metyylibentseenisulfonamidin fysikaalista muotoa sisältävän farmaseuttisen koostumuksen valmistamiseksi
FI912142L (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten 5-(2-((2-aryyli-2-hydroksietyyli)amino)propyyli)-1,3-bentsodioksolijohdannaisten valmistamiseksi
IL126674A (en) Use of cyclic and heterocyclic compounds for preparing pharmaceutical compositions inhibiting impdh activity, pharmaceutical compositions containing the same and novel thiazole and oxazole urea derivatives
ZA925573B (en) 5-membered heterocyclic compounds processes for preparing them and pharmaceutical compositions containing these compounds
NO933093D0 (no) Monohydrat av 5-(2-(4-(1,2-benzisotiazol-3-yl)-1-piperazinyl)-etyl)-6-klor-1,3-dihydro-2h-indol-2-on hydroklorid
MY131288A (en) Pyrazole carboxanilide fungicides
FI950383A0 (fi) Uusi menetelmä kiraalisen (((2-bromietyyli)amino)metyyli)-2-nitro-1H-imidatsoli-1-etanolin ja sen sukuisten yhdisteiden valmistamiseksi
ZA913445B (en) Process for preparation of 1,5-(alkylimino)-1,5-dideoxy-d-glucitol and derivatives thereof
NO894845D0 (no) Fremgangsmaate og materialer for mikrobiell bioomdannelse av toluen og andre fenylforbindelser.
FI98127B (fi) Menetelmä stabiloidun farmaseuttisen koostumuksen valmistamiseksi
EP0006564A3 (en) 2-(3.5-disubstituted-2-hydroxyphenyl)-2h-benzotriazoles, stabilized compositions containing them and method for preparing azo compounds as starting materials for the benzotriazoles
IL56513A (en) 3-(n-(acyloxyacetyl)-n-(substituted phenyl))-aminotetrahydro-2-furanone derivatives,their production and microbicidal compositions containing them
DK527585A (da) Monoethanolaminsaltet af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid paa saerlig krystallinsk form
FI955238L (fi) Uudet 5-(aryylioksimetyyli)oksatsoliinit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset
FI955387L (fi) 4(p-fluorifenyyli)-3-((3,4-(metyleenioksi)fenoksi)metyyli)-piperidiinin N-p-halobentsoyylimetyylijohdannaiset
HU910583D0 (en) Process for producing substituted oxazolidines and pharmaceutical preparatives containing these compounds as active substance
CA2051460A1 (en) Pharmaceutical compounds
BG43682A3 (en) Herbicide composition and method for control of unwanted vegetation
MX9202715A (es) Nuevos derivados de oxazol y proceso para su preparacion.
NO179575C (no) Farmasöytisk preparat inneholdende en fysikalsk form av forbindelsen N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetyl-3-metoksybenzoylÅ-2-metylbenzensulfonamid
IT1188307B (it) Ribaltatore per impianti di imballaggio di materiali pallettizzabili
NO900726L (no) Fremgangsmaate for fremstilling av gjenstander av komposittmaterialer
PH19228A (en) N-(2-(((5-dimethylamino)-methyl-2-furanyl)-methyl)-thio)-ethyl)-n'(3,4-methylenedioxybenzyl)-2-nitro-1,1-ethenediamine,process for the preparation thereof and pharmaceutical composition thereof
NO960116D0 (no) Fremgangsmåte for fremstilling av en fysikalsk form av N-[4-[5-(cyklopentyloksykarbonyl)amino-1-metylindol-3-ylmetylÅ-3-metoksybenzoylÅ-2-metylbenzensulfonamid

Legal Events

Date Code Title Description
FG Patent granted

Owner name: ZENECA LIMITED

GB Transfer or assigment of application

Owner name: ZENECA LIMITED

MA Patent expired